Massive Rs 55 Final Dividend Declared: Record Date Set For April 28; Time To Buy Before Closure?

Innovative preventative healthcare solutions are offered by Sanofi Consumer Healthcare India, a division of the multinational pharmaceutical corporation Sanofi. The firm sells consumer healthcare goods in India under well-known names including Allegra, DePURA, Avil, and Combiflam. Following the company's announcement of the record date for a large dividend distribution of Rs 55 per share, Sanofi Consumer Healthcare India's shares closed Thursday 1.42% higher at Rs 4,815 per share with a market capitalisation of Rs 11.09KCr.

Sanofi Consumer Healthcare India Dividend

"Further, in reference to outcome of the Board Meeting held on 20th February, 2025 where the Board recommended a final dividend of Rs. 55/- per equity share of the face value of Rs. 10 each, subject to the approval of Shareholders at the ensuing 2nd Annual General Meeting. In this regard, please note that the Register of Member and Share Transfer Books of the Company will remain closed from Tuesday, 29th April 2025 to Monday, 5th May 2025 (both days inclusive) for the purpose of payment of Final Dividend for the year ended 31st December 2024 ("Final Dividend"). Accordingly, the record date for the payment, shall be Monday, 28th April 2025," said Sanofi Consumer Healthcare India in a stock exchange filing.

Sanofi Consumer Healthcare India Financials

In the December quarter, the company's net profit decreased 34.8% to Rs 44.3 crore from Rs 67.9 crore in the same period the previous year. The company's revenue dropped from Rs 224.6 crore in the December 2023 quarter to Rs 170.7 crore, a 24% drop YoY. Additionally, EBITDA decreased by 30.6% in Q4 to Rs 61.1 crore from Rs 89.5 crore the year before quarter. Consequently, the company's EBITDA margin decreased from 39.9% YoY to 36.4%.

Sanofi Consumer Healthcare India Share Price Target

Mandar Bhojane - Equity Research Analyst at Choice Broking said, "SANOFI is showing early signs of recovery after a prolonged downtrend and is currently trading around ₹5,415. The stock has rebounded nearly 11% from its ₹4,900 support level, indicating renewed buying interest. A bullish candlestick formation on the daily timeframe suggests a shift in momentum, with the stock on the verge of breaking out from a falling trendline. Additionally, SANOFI has closed above its 20-day EMA and is approaching the 50-day and 200-day EMAs, which, if decisively breached, would further strengthen the bullish outlook."

"The ₹5,300 level is acting as a key support zone, where buyers have stepped in to prevent further decline. If this level holds, it could serve as a strong base for further upside movement. However, a breakdown below ₹5,300 could signal a resumption of the bearish trend, leading to renewed selling pressure. On the upside, a breakout above ₹5,500 would confirm the recovery and potentially drive the stock toward the ₹5,800-₹5,900 targets," the analyst added.

"To manage risk effectively, traders should consider a stop-loss at ₹5,100 for positions taken at the current level. Monitoring price action and trading volumes is crucial to validate the potential trend reversal before committing to new positions. A sustained move above key resistance levels, coupled with strong buying interest, would reinforce the stock's bullish trajectory in the near term," Mandar Bhojane further recommended.

Disclaimer

The recommendations made above are by market analysts and are not advised by either the author, nor Greynium Information Technologies. The author, nor the brokerage firm nor Greynium would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.